Vanda Pharmaceuticals shares jump 30% after FDA approval of Fanapt for bipolar I disorder
The biopharmaceutical company said Tuesday the latest marketing approval increases the commercial opportunity of the treatment.
—————
Boost Internet Speed–
Free Business Hosting–
Free Email Account–
Dropcatch–
Free Secure Email–
Secure Email–
Cheap VOIP Calls–
Free Hosting–
Boost Inflight Wifi–
Premium Domains–
Free Domains
